HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Betahistine Hydrochloride

HCID 68643
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
5579-84-0
Standard SMILES
CNCCc1ccccn1.Cl.Cl
InChIKey
XVDFMHARQUBJRE-UHFFFAOYSA-N
Molecular formula
C8H14Cl2N2
Average molar mass
209.11 g/mol
Monoisotopic mass
208.0534038

Overview

Betahistine Hydrochloride is the hydrochloride salt form of betahistine, a histamine analog with weak histamine H1 agonistic and more potent histamine H3 antagonistic properties. Upon intranasal administration, betahistine binds to histamine H1 and H3 receptors and exerts its agonistic and antagonistic actions locally and centrally. This promotes cochlear, vestibular and cerebral blood flow, decreases neuronal firing in the vestibular nuclei and increases histamine synthesis and release in the brain which facilitates vestibular compensation. Increased blood flow around the inner ear reduces the amount of fluid in the inner ear and may alleviate vertigo, tinnitus, and hearing loss.

Names & identifiers

Preferred name
Betahistine Hydrochloride
IUPAC
N-methyl-2-pyridin-2-ylethanamine;dihydrochloride
English name
Betahistine dihydrochloride
Molecular formula
C8H14Cl2N2
Molecular weight
209.12

Names & synonyms

Betahistine hydrochlorideBetahistine HClSercBetaserc2-Pyridineethanamine, N-methyl-, dihydrochloride2-(2-(Methylamino)ethyl)pyridine dihydrochloride49K58SMZ7UNSC-757397DTXSID102043552-[2-(Methylamino)ethyl]pyridine dihydrochlorideSerc-8Serc-16
Show more names
Betahistine Di HClPT-9SinMenierBetahistineHClBETASTINE DI HCLBetahistine 2 hcl
RefChem:567992DTXCID10126846226-966-5Betahistine dihydrochloride5579-84-0Betahistine 2HClMicroserAntivom

Database identifiers

CAS
5579-84-0
PubChem CID
68643
DTXSID
DTXSID10204355
ChEMBL
CHEMBL1446813
UNII
49K58SMZ7U
EC Number
226-966-5

Properties

Computed structural properties

Topological polar surface area
24.9 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
2
Rotatable bonds
3
Heavy atoms
12
Formal charge
0
Complexity
83.3

Physicochemical properties

Melting point
150 · 150-154 °C
storage temp.
2 · 2-8°C
solubility
Very soluble in water, soluble in ethanol (96 per cent), practically insoluble in 2propanol.
form
powder
color
Pale Yellow
Stability
Hygroscopic
InChI
InChI=1S/C8H12N2.2ClH/c1-9-7-5-8-4-2-3-6-10-8;;/h2-4,6,9H,5,7H2,1H3;2*1H
InChIKey
XVDFMHARQUBJRE-UHFFFAOYSA-N
SMILES
C1(CCNC)=NC=CC=C1.Cl.Cl
CAS DataBase Reference
5579 · 5579-84-0(CAS DataBase Reference)
EWG's Food Scores
1 · 1
FDA UNII
49 K58SMZ7U · 49K58SMZ7U
UNSPSC Code
41116107 · 41116107
NACRES
24 · NA.24
Protein binding
0 · 0-5%
Excreted unchanged in urine
85 · 85-90%

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 5 items

This chemical does not meet GHS hazard criteria for 1.8% (1 of 55) of reports.

Warning

H315 (94.5%): Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P271, P273, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 55 reports by companies from 13 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Other Safety InformationIMAP assessments - 2-Pyridineethanamine, N-methyl-, dihydrochloride: Environment tier I assessment
Hazard Classes and CategoriesSkin Irrit. 2 (94.5%)

Safety data

PPE
Eyeshields, Gloves, type N95 (US)
wgk
3
rtecs
UT2969000
hs_code
29333990
Signal word
Warning
Symbol(GHS)
GHS07
safety_code
24/25
Storage Class
11 - Combustible Solids
Hazard statements
H413-H319-H315-H335
Precautionary statements
P264-P280-P305+P351+P338-P337+P313P-P264-P280-P302+P352-P321-P332+P313-P362

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 2 items

Drugs used to cause dilation of the blood vessels.

Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically.

Applications · 4 items

DescriptionBetahistine dihydrochloride (BH.2HCl) is an orally active histamine analog which has been used to control vertigo, lack of hearing and tinnitus related to Ménière’s disease. The mechanism of BH.2HCl is to reduce the pressure of the membranous labyrinth that results in enhancement of the microvasculature circulation and improves the signs of Ménière’s disease. Peroral administration undergoes extensive first-pass metabolism and gastric irritation in patients with peptic ulcer. In treatment of vertigo, a uniform and constant supply of drug is required in order to maintain steady-state concentration of the drug in the body. Unfortunately, BH.2HCl possesses a short half-life of about 3–4 h and requires frequent administration of the drug,12–15 thereby making it an ideal candidate for controlled release preparations.

UsesBetahistine is belongs to a group of medications used to treat vertigo associated with Ménière's disease. Vertigo is a condition that causes sufferers to have a sensation of rotation or movement of themselves or their surroundings. Ménière's disease is a disorder of the inner ear that causes vertigo in addition to symptoms such as ringing in the ears, headache, and loss of hearing.Betahistine is used to reduce the number of episodes of vertigo associated with Ménière's disease. It is believed to work by decreasing the pressure in the ear. This pressure is believed to contribute to the sense of dizziness, nausea, and ringing in the ears and hearing loss that people with Ménière's disease experience.

Usestherapeutic for thrombocytopenia, effective against idiopathic thrombocytopenic purpura and cirrhosis due to hepatitis C.

General DescriptionPharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Biological half-life
3.4 · 3.4 / -
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
413 · H413-H319-H315-H335
Precautionary statements
264 · P264-P280-P305+P351+P338-P337+P313P-P264-P280-P302+P352-P321-P332+P313-P362
PPE
95 · Eyeshields, Gloves, type N95 (US)
Safety Statements
24 · 24/25
WGK Germany
3 · 3
RTECS
2969000 · UT2969000
HS Code
29333990 · 29333990
Storage Class
11 · 11 - Combustible Solids

Upstream & downstream products

Downstream products

N-Methyl-N,N-bis(2-pyridylethyl)amine